Presentation
Uriach Pharma, is the business unit within the Uriach Group, and its goal is to market prescription pharmaceutical specialities, derived from their own R+D, and also from licences from other multinationals.
The products marketed and sold by Uriach Pharma, cover a wide range of therapeutic possibilities: antiplatelet drugs, anti-hypertensive agents, anti-histaminics, treatment for controlling asthma, antibiotics, anti-mycotics and anti-anemics.
Uriach Pharma is working with a clearly marked strategy. Its main lines of action are to continually evolve the product portfolio so as to offer the largest possible therapeutic coverage, and to enhance its own research products, both on a commercial level, and in terms of studying and conducting new developments.
On an international level, Uriach Pharma, is present in over 55 countries, where they market their own research products. This internationalisation is evident in the expansion process, with new markets being added each year.
Uriach Pharma feels a commitment to the health professional and to contributing to improving citizen health and wellbeing.
